Lambeir Anne-Marie, Proost Paul, Scharpé Simon, De Meester Ingrid
Laboratory of Medical Biochemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1 S6, B-2610 Wilrijk, Belgium.
Biochem Pharmacol. 2002 Dec 15;64(12):1753-6. doi: 10.1016/s0006-2952(02)01415-6.
In vivo inactivation of glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) was found to be associated with the proteolytic removal of their N-terminal dipeptide by the ectopeptidase dipeptidyl peptidase IV (DPP IV). Previous studies suggested that the in vivo metabolism of GLP-1 is much faster than that of GLP-2. In this paper, we investigated the in vitro truncation of GLP-2 and GLP-1 by DPP IV. The slower conversion rate observed for GLP-2 compared to GLP-1 was due to an approximately 10-fold reduction in catalytic rate constant. The selectivity of DPP IV for the glucagon-like peptides was compared with data obtained for other natural substrates using the same enzyme source in identical conditions.
胰高血糖素样肽-1(GLP-1)和胰高血糖素样肽-2(GLP-2)的体内失活被发现与外肽酶二肽基肽酶IV(DPP IV)对其N端二肽的蛋白水解去除有关。先前的研究表明,GLP-1的体内代谢比GLP-2快得多。在本文中,我们研究了DPP IV对GLP-2和GLP-1的体外截短。与GLP-1相比,GLP-2观察到的较慢转化率是由于催化速率常数降低了约10倍。在相同条件下,使用相同的酶源,将DPP IV对胰高血糖素样肽的选择性与其他天然底物的数据进行了比较。